When a global pandemic forced the industry into unprecedented action, the global scientific community collaborated in exceptional ways and public-private partnerships drove innovation to address a common need with two highlights standing out: technology and science.
- Technology enabled people to make the shift and work from home, care for patients at a distance, conduct clinical trials virtually and reconfigure supply chains.
- Science enabled multiple COVID-19 vaccines to be developed in record time despite the remote working environment.
But, how can we use the lessons of COVID-19 to help us address system and patient-level affordability issues, while still advancing the discovery, development and delivery of new treatments for all health conditions?
Our research found three ways New Science can support and deliver the innovation that today’s economics demand.